Among the potential transcriptional regulators, YAP was selected for further validation because of its significant nuclear translocation and enriched YAP/TAZ transcriptional activity according to KEGG analysis (Figure 5A) after OX40L treatment and its crucial role in tumor progression (Figure 5D and Supplemental Table 2). The gene discussed is YAP1; the disease is neoplasm.